Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135486567> ?p ?o ?g. }
- W2135486567 endingPage "720" @default.
- W2135486567 startingPage "715" @default.
- W2135486567 abstract "To determine the value of the level of anti-topoisomerase I (anti-topo I) to evaluate lung involvement defined by abnormal high-resolution computed tomography (HRCT) score and pulmonary function tests (PFTs) in systemic sclerosis (SS).Forty-eight patients with SS, 20 with lung involvement and 28 with no lung involvement.PFT measurement, HRCT scoring of lung involvement, and anti-topo I assay by enzyme-linked immunosorbent assay. Normal anti-topo I level was defined as < 30.There was a significant association between cutaneous extent and anti-topo I level (6.5% of patients with limited cutaneous scleroderma had abnormal anti-topo I levels vs 70.6% of patients with diffuse cutaneous scleroderma, p = 0.0001). In patients with diffuse cutaneous scleroderma, pulmonary involvement was associated with a higher percentage of abnormal anti-topo I level: 91.7% vs 20% (p = 0.010). In patients with diffuse cutaneous scleroderma, a significant association was found between the class of anti-topoII level and total lung capacity (median, 69 in patients with abnormal anti-topo I level vs 87 in patients with normal anti-topo I level, p = 0.010), between the class of anti-topo I level and HRCT score (median, 12 in patients with abnormal anti-topo I level vs 5 in patients with normal anti-topo I level, p = 0.05).Anti-topo I can be considered as a marker of lung involvement in patients with diffuse cutaneous scleroderma." @default.
- W2135486567 created "2016-06-24" @default.
- W2135486567 creator A5003360902 @default.
- W2135486567 creator A5007455518 @default.
- W2135486567 creator A5016494012 @default.
- W2135486567 creator A5027099014 @default.
- W2135486567 creator A5058894297 @default.
- W2135486567 creator A5066851139 @default.
- W2135486567 creator A5090924104 @default.
- W2135486567 date "1999-09-01" @default.
- W2135486567 modified "2023-10-07" @default.
- W2135486567 title "Is Anti-Topoisomerase I a Serum Marker of Pulmonary Involvement in Systemic Sclerosis?" @default.
- W2135486567 cites W1481243105 @default.
- W2135486567 cites W1970502168 @default.
- W2135486567 cites W1977209683 @default.
- W2135486567 cites W2002027999 @default.
- W2135486567 cites W2023466198 @default.
- W2135486567 cites W2028921539 @default.
- W2135486567 cites W2035688290 @default.
- W2135486567 cites W2042385706 @default.
- W2135486567 cites W2048994188 @default.
- W2135486567 cites W2070399299 @default.
- W2135486567 cites W2081028616 @default.
- W2135486567 cites W2081429897 @default.
- W2135486567 cites W2121185030 @default.
- W2135486567 cites W2126125033 @default.
- W2135486567 cites W2127188787 @default.
- W2135486567 cites W2130945009 @default.
- W2135486567 cites W2137172804 @default.
- W2135486567 cites W2149524554 @default.
- W2135486567 cites W2150383459 @default.
- W2135486567 cites W2153709755 @default.
- W2135486567 cites W2170166200 @default.
- W2135486567 cites W2273415510 @default.
- W2135486567 cites W2912700915 @default.
- W2135486567 cites W2994597783 @default.
- W2135486567 cites W4231866775 @default.
- W2135486567 doi "https://doi.org/10.1378/chest.116.3.715" @default.
- W2135486567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10492277" @default.
- W2135486567 hasPublicationYear "1999" @default.
- W2135486567 type Work @default.
- W2135486567 sameAs 2135486567 @default.
- W2135486567 citedByCount "50" @default.
- W2135486567 countsByYear W21354865672012 @default.
- W2135486567 countsByYear W21354865672013 @default.
- W2135486567 countsByYear W21354865672014 @default.
- W2135486567 countsByYear W21354865672016 @default.
- W2135486567 countsByYear W21354865672017 @default.
- W2135486567 countsByYear W21354865672018 @default.
- W2135486567 countsByYear W21354865672019 @default.
- W2135486567 countsByYear W21354865672020 @default.
- W2135486567 countsByYear W21354865672023 @default.
- W2135486567 crossrefType "journal-article" @default.
- W2135486567 hasAuthorship W2135486567A5003360902 @default.
- W2135486567 hasAuthorship W2135486567A5007455518 @default.
- W2135486567 hasAuthorship W2135486567A5016494012 @default.
- W2135486567 hasAuthorship W2135486567A5027099014 @default.
- W2135486567 hasAuthorship W2135486567A5058894297 @default.
- W2135486567 hasAuthorship W2135486567A5066851139 @default.
- W2135486567 hasAuthorship W2135486567A5090924104 @default.
- W2135486567 hasConcept C126322002 @default.
- W2135486567 hasConcept C142724271 @default.
- W2135486567 hasConcept C147897179 @default.
- W2135486567 hasConcept C180032290 @default.
- W2135486567 hasConcept C181199279 @default.
- W2135486567 hasConcept C185592680 @default.
- W2135486567 hasConcept C2777524225 @default.
- W2135486567 hasConcept C2777714996 @default.
- W2135486567 hasConcept C2778751314 @default.
- W2135486567 hasConcept C2779625490 @default.
- W2135486567 hasConcept C2779967694 @default.
- W2135486567 hasConcept C55493867 @default.
- W2135486567 hasConcept C71924100 @default.
- W2135486567 hasConcept C75603125 @default.
- W2135486567 hasConcept C90924648 @default.
- W2135486567 hasConceptScore W2135486567C126322002 @default.
- W2135486567 hasConceptScore W2135486567C142724271 @default.
- W2135486567 hasConceptScore W2135486567C147897179 @default.
- W2135486567 hasConceptScore W2135486567C180032290 @default.
- W2135486567 hasConceptScore W2135486567C181199279 @default.
- W2135486567 hasConceptScore W2135486567C185592680 @default.
- W2135486567 hasConceptScore W2135486567C2777524225 @default.
- W2135486567 hasConceptScore W2135486567C2777714996 @default.
- W2135486567 hasConceptScore W2135486567C2778751314 @default.
- W2135486567 hasConceptScore W2135486567C2779625490 @default.
- W2135486567 hasConceptScore W2135486567C2779967694 @default.
- W2135486567 hasConceptScore W2135486567C55493867 @default.
- W2135486567 hasConceptScore W2135486567C71924100 @default.
- W2135486567 hasConceptScore W2135486567C75603125 @default.
- W2135486567 hasConceptScore W2135486567C90924648 @default.
- W2135486567 hasIssue "3" @default.
- W2135486567 hasLocation W21354865671 @default.
- W2135486567 hasLocation W21354865672 @default.
- W2135486567 hasOpenAccess W2135486567 @default.
- W2135486567 hasPrimaryLocation W21354865671 @default.
- W2135486567 hasRelatedWork W1995845852 @default.
- W2135486567 hasRelatedWork W2001320879 @default.
- W2135486567 hasRelatedWork W2003340324 @default.